September 14, 2010 — Merck has announced that its antipsychotic asenapine (Saphris), in sublingual dissolving tablet form, has been approved for expanded use by the US Food and Drug Administration ...

Buprenorphine sublingual tablet is prescribed to treat opioid use disorder in two phases: an induction phase to manage initial withdrawal symptoms and a maintenance phase for long-term treatment. You ...

Zolpidem tartrate 1.75mg, 3.5mg. Use lowest effective dose. Effects delayed if taken with or after a meal. Place 1 tab under the tongue and allow to disintegrate completely before swallowing. Take ...

CHATHAM, N.J., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biotechnology company, today announced that the U.S. Food and Drug ...

Unique sublingual formulation designed for bedtime dosing bypasses first-pass metabolism, optimizing parent-drug exposure during sleep and decreasing levels of the persistent active metabolite The ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

In August 2025, the US Food and Drug Administration (FDA) approved Tonmya ® (cyclobenzaprine hydrochloride sublingual tablets; Tonix Pharmaceuticals) for the treatment of fibromyalgia in adults. Study ...